Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  (±)17-HETE

(±)17-HETE

Basic information Safety Supplier Related

(±)17-HETE Basic information

Product Name:
(±)17-HETE
Synonyms:
  • (±)17-HETE
  • OPPIPPRXLIDJKN-JPURVOHMSA-N
  • 5,8,11,14-Eicosatetraenoic acid, 17-hydroxy-, (5Z,8Z,11Z,14Z)-
  • 17-hydroxy-5(Z),8(Z),11(Z),14(Z)-eicosatetraenoic acid
  • 17-hydroxy-5(Z),8(Z),11(Z),14(Z)-ETA
CAS:
128914-47-6
MF:
C20H32O3
MW:
320.47
Mol File:
128914-47-6.mol
More
Less

(±)17-HETE Chemical Properties

storage temp. 
Store at -20°C
solubility 
0.1 m Na2CO3: 2 mg/ml; DMF: Miscible; DMSO: Miscible; Ethanol: Miscible; PBS (pH 7.2): 0.8 mg/ml
More
Less

(±)17-HETE Usage And Synthesis

Description

Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)17-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney. At a concentration of 2 μM the (S)-enantiomer of 17-HETE inhibits proximal tubule ATPase activity by as much as 70%, whereas the (R)-isomer is inactive.

Uses

17-HETE is arachidonic acid metabolite through cytochrome P-450 pathways, which consists of 17R-HETE and 17S-HETE enantiomers. 17-HETE serves as allosteric activator of the cytochrome P450 1B1 and inhibitor of ATPase, induces cardic hypertrophy[1][2].

Definition

ChEBI: A HETE that consists of arachidonic acid bearing an additional hydroxy substituent at position 17.

in vivo

17-HETE (1-20 μg, i.a.) stereospecificially inhibits proximal tubule ATPase activity with S- enantiomer in New Zealand white rabbit[2].

Animal Model:New Zealand White rabbit[2]
Dosage:1-20 μg
Administration:injection into artery
Result:17S inhibited more than 70% ATPase activity at the concentration of 2 μM, while 17R enantiomer remained inactive.

IC 50

CYP1B1

References

[1] Isse FA, et al., 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners. Prostaglandins Other Lipid Mediat. 2023 Oct;168:106749. DOI:10.1016/j.prostaglandins.2023.106749
[2] Carroll MA, e al., Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol. 1996 Oct;271(4 Pt 2):R863-9. DOI:10.1152/ajpregu.1996.271.4.R863

(±)17-HETESupplier

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Yichang Zhongyitai Trading Co., Ltd.
Tel
0717-6449896 13886658719
Email
root@zhongyitai.com
Alfa Chemistry
Tel
1-516-6625404
Email
support@alfa-chemistry.com
Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Email
sales@chemegen.com